DBAF-301

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameDBAF-301
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCommunity Acquired Pneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesioGenetics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesioGenetics LLC
Active IndicationsN/A
Inactive IndicationsCommunity Acquired Pneumonia

Other Information

ATC CodeN/A
Related LinksN/A